Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Carcinogenesis

• Publication date

  1992-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CARCIN/13.6.1019PMID 1600605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats.

  1991cited by this paper
• Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats.

  1991cited by this paper
• Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water.

  1991cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• Nonsteroidal antiinflammatory drugs--differences and similarities.

  1991cited by this paper
• A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

  1991cited by this paper
• Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats.

  1990cited by this paper
• Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.

  1990cited by this paper
• Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.

  1990cited by this paper
• Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats.

  1988cited by this paper
• Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma model.

  1988cited by this paper
• Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3.

  1988cited by this paper
• Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.

  1987cited by this paper
• Inhibition of the specific binding of 12-O-tetradecanoylphorbol-13-acetate to mouse epidermal membrane fractions by glycyrrhetic acid.

  1986cited by this paper
• Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis.

  1986cited by this paper
• Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil.

  1986cited by this paper
• Naturally occurring anticarcinogenic substances in foodstuffs.

  1985cited by this paper
• Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea.

  1984cited by this paper
• Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7,12-dimethylbenz[a]anthracene plus teleocidin.

  1984cited by this paper
• Response of human adenocarcinoma to chemotherapy: as sole agents and in combination with sodium ibuprofen.

  1984cited by this paper
• Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse, Peromyscus maniculatus.

  1984cited by this paper
• Colon cancer and dietary fat, phosphate, and calcium: a hypothesis.

  1984cited by this paper
• Prostaglandins and cancer

  1983cited by this paper
• Oral mucosal tumor inhibition by ibuprofen.

  1983cited by this paper
• Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats.

  1983cited by this paper
• Pharmacokinetics of piroxicam in man.

  1983cited by this paper
• The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat.

  1983cited by this paper
• Prostaglandins and human lung carcinomas.

  1982cited by this paper
• Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment.

  1981cited by this paper
• Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats.

  1980cited by this paper
• Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

  1980cited by this paper
• Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study.

  1980cited by this paper
• Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole.

  1978cited by this paper
• Prostaglandins and the immune response.

  1977cited by this paper
• Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin.

  1977cited by this paper
• Investigations into the metabolism and mode of action of the colon carcinogens 1,2‐dimethylhydrazine and azoxymethane

  1977cited by this paper
• Antigen stimulation of prostaglandin synthesis and control of immune responses.

  1976cited by this paper
• Human breast tumour-induced osteolysis and prostaglandins.

  1976cited by this paper
• Proceedings: Prostaglandins in human colonic carcinoma.

  1975cited by this paper
• Prostaglandins and cancer: an update.

  1974cited by this paper
• Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin.

  1972cited by this paper
• Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds.

  1972cited by this paper
• THE ANTI‐INFLAMMATORY ACTIVITY OF GLYCYRRHETINIC ACID AND DERIVATIVES

  1958cited by this paper

• Synthetic Methods of Medicinally Important Heterocycles-thiazines: A Review

  2020cites this paper
• Improved Solubility of Morin Using p-sulphonatocalix[4]arene as Encapsulating Agent: HPLC Analysis and their Molecular Modelling

  2020cites this paper
• Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

  2019cites this paper
• Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

  2019cites this paper
• Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation

  2018cites this paper
• Assessing the value of enrofloxacin and carprofen combination treatment in southern white rhinoceros (Ceratotherium simum) through the use of pharmacokinetic modelling

  2018cites this paper
• Loss of inversin contributes to renal cystic disease through altered cellular processes and decreased sodium transport in renal epithelial cells

  2017cites this paper
• POLYMORPHISM OF THE COX-2 GENE AND SUSCEPTIBILITY TO COLON AND RECTAL CANCER

  2017cites this paper
• Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention.

  2016cites this paper
• Chemopreventive effect of α-viniferin in azoxymethane-induced mouse colorectal tumor and Caco-2 cells

  2015cites this paper
• Ibuprofen in the Prevention and Therapy of Cancer

  2015cites this paper
• Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers

  2015cites this paper
• Carcinogenic Process Cancer Depends on Time of Administration during Chemopreventive Efficacy of Sulindac Sulfone against Colon

  2013cites this paper
• Chemoprevention: making it a success story for controlling human cancer.

  2012cites this paper
• Suppressive effects of Moringa oleifera Lam pod against mouse colon carcinogenesis induced by azoxymethane and dextran sodium sulfate.

  2011cites this paper
• Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention

  2011influential citation
• NSAIDs and Coxibs in Chemoprevention Non-steroidal Anti-inflammatory Drugs and Coxibs In Chemoprevention : A Commentary Based Primarily on Animal Studies

  2011cites this paper
• The role of seminal plasma in cervical carcinoma

  2010cites this paper
• The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis.

  2010cites this paper
• Lipoxygenase Inhibitors and Gamma-Radiat ion in vitro

  2010cites this paper
• Ketoprofen in topical formulation decreases the matrix metalloproteinase‐2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma

  2009cites this paper
• p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells.

  2008cites this paper
• Probiotics Regulate the Expression of COX-2 in Intestinal Epithelial Cells

  2008cites this paper
• Citrus Compounds Inhibit Inflammation- and Obesity-Related Colon Carcinogenesis in Mice

  2008cites this paper
• Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.

  2007cites this paper
• Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.

  2007cites this paper
• Lack of Enhancing Effect of Lauric Acid on the Development of Aberrant Crypt Foci in Male ICR Mice Treated with Azoxymethane and Dextran Sodium Sulfate

  2007cites this paper
• Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.

  2007cites this paper
• Colon Cancer : An Approach from Molecular Epidemiology

  2007cites this paper
• Strategies for colon cancer prevention: combination of chemopreventive agents.

  2007cites this paper
• Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.

  2006cites this paper
• Coxibs and Cancer Prevention

  2006cites this paper
• Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis‐related colon carcinogenesis in mice

  2006cites this paper
• Chemoprophylaxis of colon cancer

  2006cites this paper
• Effects of high corn oil diet on preneoplastic murine colons: Prostanoid production and lipid composition

  2006cites this paper
• Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.

  2006cites this paper
• Advances in Brief G 1 DelayinCellsOverexpressingProstaglandinEndoperoxideSynthase-2 '

  2006cites this paper
• Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX‐2 inhibition

  2006cites this paper
• Advances in Brief Chemopreventive Activity of Celecoxib , a Specific Cyclooxygenase-2 Inhibitor , against Colon Carcinogenesis 1

  2006cites this paper
• Factors InvolvedinCOX-2 Inhibition

  2005cites this paper
• 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?

  2005cites this paper
• Effects of Nonselective Cyclooxygenase Inhibition with Low-Dose Ibuprofen on Tumor Growth, Angiogenesis, Metastasis, and Survival in a Mouse Model of Colorectal Cancer

  2005cites this paper
• Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

  2005cites this paper
• Chemoprophylaxis of colon cancer

  2005cites this paper
• Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

  2005cites this paper
• Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

  2005cites this paper
• Cyclooxygenase-2 Inhibition Prevents Colorectal Cancer: From the Bench to the Bed Side

  2005cites this paper
• Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2

  2005cites this paper
• Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation.

  2005cites this paper
• Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

  2004cites this paper
• Tumor induction and prophylaxis following different forms of intestinal urinary diversion in a rat model

  2004cites this paper
• Effect of ketoprofen in topical formulation on vascular endothelial growth factor expression and tumor growth in nude mice with osteosarcoma

  2004cites this paper
• Clinical development plan: Ibuprofen

  2004cites this paper
• Clinical development plan: Piroxicam

  2004cites this paper
• NSAIDs and chemoprevention.

  2004cites this paper
• Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease

  2003cites this paper
• IARC Handbooks of Cancer prevention

  2003cites this paper
• Epidemiology of Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer

  2003cites this paper
• Role of Synthetic and Naturally Occurring Cyclooxygenase Inhibitors in Colon Cancer Prevention

  2003cites this paper
• Animal Models for Colon Cancer Chemoprevention

  2002cites this paper
• The role of nutrition and chemoprevention in colorectal cancer: from observations to expectations.

  2002cites this paper
• Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.

  2002cites this paper
• COX selectivity and animal models for colon cancer.

  2002cites this paper
• Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.

  2002cites this paper
• AH6809 antagonizes non-small cell lung cancer prostaglandin receptors.

  2002cites this paper
• ONE POT SYNTHESIS OF 7-METHOXY/6-SULFONYL-4H-1, 4-BENZOTHIAZINES

  2002cites this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cites this paper
• Iron as a comorbid factor in chronic viral hepatitis

  2002cites this paper
• Most Effective Colon Cancer Chemopreventive Agents in Rats: A Systematic Review of Aberrant Crypt Foci and Tumor Data, Ranked by Potency

  2002cites this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001cites this paper
• Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.

  2001cites this paper
• Suppression of Occurrence and Advancement of β‐Catenin‐accumulated Crypts, Possible Premalignant Lesions of Colon Cancer, by Selective Cyclooxygenase‐2 Inhibitor, Celecoxib

  2001cites this paper
• Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats.

  2001cites this paper
• Chemoprevention and therapy of Mammary Carcinogenesis by Prostaglandin H Synthase-2 (COX-2) inhibition /

  2001cites this paper
• Análisis de la participación y cumplimiento de la prueba de cribado en un programa de detección precoz de la neoplasia colorrectal. Influencia de la forma de contacto con la población diana

  2001cites this paper
• Testing for colon neoplasia susceptibility variants at the human COX2 locus.

  2001cites this paper
• Do NSAIDs prevent colorectal cancer?

  2000cites this paper
• Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.

  2000cites this paper
• Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

  2000cites this paper
• Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs.

  2000cites this paper
• Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs.

  2000cites this paper
• NSAIDs as Cancer Preventive Agents.

  2000influential citation
• Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.

  2000cites this paper
• Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors.

  2000cites this paper
• Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.

  2000cites this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cites this paper
• Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.

  2000cites this paper
• Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.

  2000cites this paper
• Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.

  2000cites this paper
• Advances in Brief Chemoprevention of Breast Cancer in Rats by Celecoxib , a Cyclooxygenase 2 Inhibitor 1

  2000cites this paper
• Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats.

  2000cites this paper
• COX-2 and iNOS, good targets for chemoprevention of colon cancer.

  2000cites this paper
• Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.

  1999influential citation
• Short-and medium-term carcinogenicity tests: simple initiation-promotion assay systems.

  1999cites this paper
• Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

  1999cites this paper
• A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors

  1999cites this paper
• Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.

  1999cites this paper
• Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin.

  1999cites this paper
• Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression.

  1999cites this paper
• Advances in Brief Role of the Prostaglandin E Receptor Subtype EP 1 in Colon Carcinogenesis 1

  1999cites this paper